From: Effect of low dose aspirin application during pregnancy on fetal congenital anomalies
Variables | OR | 95% CI | P value |
---|---|---|---|
Age | 1.01 | 0.96–1.07 | 0.640 |
BMI | 0.94 | 0.86–1.02 | 0.124 |
Number of previous spontaneous abortions | 1.15 | 1.00–1.31 | 0.040 |
History of previous preterm births | 1.36 | 0.18–10.17 | 0.766 |
History of fetal congenital anomalies | 3.22 | 1.12–9.20 | 0.029 |
Diabetes mellitus | 1.09 | 0.64–1.88 | 0.745 |
Twin pregnancy | 1.82 | 0.72–4.59 | 0.208 |
LDA exposure during pregnancy | 1.20 | 0.77–1.89 | 0.421 |
Duration of LDA exposure | 1.00 | 0.99–1.00 | 0.761 |
Time of exposure to LDA during pregnancy | |||
Exposure during the first trimester | 0.86 | 0.56–1.33 | 0.505 |
Exposure during the second trimester | 1.07 | 0.69–1.67 | 0.761 |
Exposure during the third trimester | 0.80 | 0.52–1.23 | 0.316 |
Exposure to prednisone during pregnancy | 0.76 | 0.49–1.19 | 0.233 |